Workflow
益盛药业:第九届监事会第二次会议决议公告

Core Viewpoint - Yisheng Pharmaceutical announced the approval of its 2025 semi-annual report and summary by the second meeting of the ninth supervisory board [2] Group 1 - The announcement was made on the evening of August 22 [2] - The report includes financial performance and operational updates for the first half of 2025 [2]